SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ANDRX (ADRX) -- Ignore unavailable to you. Want to Upgrade?

To: cool who wrote (76)4/27/1998 8:53:00 AM
From: scaram(o)uche  Read Replies (2) | Respond to of 127
 
John Long:

There are a lot of things being claimed on the MDIX thread. I, for one, assume that MDIX will be bankrupt by the time that a judge or jury can award punitive damages, and that the MDIX affair will thus have little impact on ADRX other than the hassle factor.

Do you have any facts rather than claims to discuss? We are investors in a $40 stock, a company where product sales and FDA submissions, rather than claims, move the share price.

Rick



To: cool who wrote (76)4/27/1998 9:09:00 AM
From: Emec  Read Replies (1) | Respond to of 127
 
I pulled an article off Wall Street Journal today but do not see it in the hard copy of the paper.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News